A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
本文档由 papillary1 分享于2016-07-18 09:21
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~